BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38709710)

  • 1. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
    PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
    BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis.
    Sharma K; Sharma M; Shree R; Singla N; Joshi H; Modi T; Goyal M; Sharma A; Sharma N; Modi M
    Tuberculosis (Edinb); 2024 Jul; 147():102513. PubMed ID: 38547569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
    Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA
    Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.
    Dartois V; Barry CE
    Curr Clin Pharmacol; 2010 May; 5(2):96-114. PubMed ID: 20156156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study.
    Diriba G; Alemu A; Tola HH; Yenew B; Amare M; Eshetu K; Sinshaw W; Abebaw Y; Meaza A; Seid G; Moga S; Zerihun B; Getu M; Dagne B; Mollalign H; Tadesse M; Buta B; Wordofa N; Alemu E; Erresso A; Hailu M; Tefera Z; Wondimu A; Belhu T; Gamtesa DF; Getahun M; Kebede A; Abdela S
    IJID Reg; 2022 Dec; 5():39-43. PubMed ID: 36176268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
    Pang Y; Dong H; Tan Y; Deng Y; Cai X; Jing H; Xia H; Li Q; Ou X; Su B; Li X; Zhang Z; Li J; Zhang J; Huan S; Zhao Y
    Sci Rep; 2016 May; 6():25330. PubMed ID: 27149911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences of Mycobacterium tuberculosis complex infection and multidrug resistance epidemic in Luoyang.
    Wang Z; Guo T; Xu L; Liu J; Hou Y; Jin J; Zhang Q; Jiang T; Zhao Z; Xue Y
    BMC Infect Dis; 2024 Jun; 24(1):578. PubMed ID: 38862881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of fluoroquinolone resistance among drug resistant tuberculosis patients at a tertiary care facility in Karachi, Pakistan.
    Zaidi SMA; Haseeb A; Habib SS; Malik A; Khowaja S; SaifUllah N; Rizvi N
    BMC Res Notes; 2017 Jul; 10(1):313. PubMed ID: 28743312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.
    Migliori GB; Sotgiu G; Gandhi NR; Falzon D; DeRiemer K; Centis R; Hollm-Delgado MG; Palmero D; Pérez-Guzmán C; Vargas MH; D'Ambrosio L; Spanevello A; Bauer M; Chan ED; Schaaf HS; Keshavjee S; Holtz TH; Menzies D;
    Eur Respir J; 2013 Jul; 42(1):169-179. PubMed ID: 23060633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.
    Guo J; Han Y; Zhang X; Lin F; Chen L; Feng X
    BMC Infect Dis; 2024 May; 24(1):511. PubMed ID: 38773443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and transmission of drug-resistant tuberculosis in a Russian population.
    Casali N; Nikolayevskyy V; Balabanova Y; Harris SR; Ignatyeva O; Kontsevaya I; Corander J; Bryant J; Parkhill J; Nejentsev S; Horstmann RD; Brown T; Drobniewski F
    Nat Genet; 2014 Mar; 46(3):279-86. PubMed ID: 24464101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.
    Falzon D; Gandhi N; Migliori GB; Sotgiu G; Cox HS; Holtz TH; Hollm-Delgado MG; Keshavjee S; DeRiemer K; Centis R; D'Ambrosio L; Lange CG; Bauer M; Menzies D;
    Eur Respir J; 2013 Jul; 42(1):156-68. PubMed ID: 23100499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.
    Rosenthal A; Gabrielian A; Engle E; Hurt DE; Alexandru S; Crudu V; Sergueev E; Kirichenko V; Lapitskii V; Snezhko E; Kovalev V; Astrovko A; Skrahina A; Taaffe J; Harris M; Long A; Wollenberg K; Akhundova I; Ismayilova S; Skrahin A; Mammadbayov E; Gadirova H; Abuzarov R; Seyfaddinova M; Avaliani Z; Strambu I; Zaharia D; Muntean A; Ghita E; Bogdan M; Mindru R; Spinu V; Sora A; Ene C; Vashakidze S; Shubladze N; Nanava U; Tuzikov A; Tartakovsky M
    J Clin Microbiol; 2017 Nov; 55(11):3267-3282. PubMed ID: 28904183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating the evolutionary pathway to multidrug-resistant outbreaks of a Mycobacterium tuberculosis L4.1.2.1/Haarlem sublineage.
    Dekhil N; Mardassi H
    Int J Infect Dis; 2024 Jul; 144():107077. PubMed ID: 38697608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
    Shah NS; Auld SC; Brust JC; Mathema B; Ismail N; Moodley P; Mlisana K; Allana S; Campbell A; Mthiyane T; Morris N; Mpangase P; van der Meulen H; Omar SV; Brown TS; Narechania A; Shaskina E; Kapwata T; Kreiswirth B; Gandhi NR
    N Engl J Med; 2017 Jan; 376(3):243-253. PubMed ID: 28099825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do Mutations of Mycobacterium Genes Cause Drug Resistance in Tuberculosis?
    Hou K; Jabeen R; Sun L; Wei J
    Curr Pharm Biotechnol; 2024; 25(6):724-736. PubMed ID: 37888812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and spatial analysis reveal the transmission dynamics of tuberculosis in areas with high incidence of Zhejiang, China: A prospective cohort study.
    Liu Z; Li X; Xiong H; Zhou Q; Yi H; Wu K; Zhou Z; Lu Y; Zhu Y; Zhou L; Zhang M; Gao J; Gao J; Chen S; Wang X; Wang W
    Infect Genet Evol; 2024 Jul; 121():105603. PubMed ID: 38723983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired bedaquiline and fluoroquinolones resistance during treatment follow-up in Oromia Region, North Shewa, Ethiopia.
    Diriba G; Alemu A; Ayano BZ; Yenew B; Hailu M; Buta B; Wondimu A; Tefera Z; Ababu Z; Ebisa Y; Moga S; Tadesse G
    IDCases; 2024; 36():e01988. PubMed ID: 38779144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
    Bobba S; Khader SA
    Trends Immunol; 2023 Sep; 44(9):712-723. PubMed ID: 37543504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.